The last time FibroGen raised money was a $56.5 million series E round in September 2000 - shortly after the genomics bubble burst. That left the prelinical company with a hefty post-money valuation around $280 million....

Jerini (Berlin, Germany) raised EUR 15.5 million ($19.9 million) in a second closing of its June 2004 series B round, bringing to EUR 46.5 million the total raised in the round. Investors in the second...

More than three years after the last biotech IPO in Germany, there's a glimmer of light at the end of the tunnel, as companies are starting to talk about the possibility of going public in...

Cancer, autoimmune and inflammation company Jerini (Berlin, Germany) raised EUR 31 million ($38.1 million) in a series B round co-led by HealthCap; TVM Techno Venture Management; and 3i. Other investors included Sanders Morris Harris; PolyTechnos...